PL2633865T3 - Zastosowanie interleukiny-22 w leczeniu wirusowego zapalenia wątroby - Google Patents
Zastosowanie interleukiny-22 w leczeniu wirusowego zapalenia wątrobyInfo
- Publication number
- PL2633865T3 PL2633865T3 PL11821115T PL11821115T PL2633865T3 PL 2633865 T3 PL2633865 T3 PL 2633865T3 PL 11821115 T PL11821115 T PL 11821115T PL 11821115 T PL11821115 T PL 11821115T PL 2633865 T3 PL2633865 T3 PL 2633865T3
- Authority
- PL
- Poland
- Prior art keywords
- interleukin
- viral hepatitis
- treating viral
- treating
- hepatitis
- Prior art date
Links
- 206010019799 Hepatitis viral Diseases 0.000 title 1
- 102100030703 Interleukin-22 Human genes 0.000 title 1
- 108010074109 interleukin-22 Proteins 0.000 title 1
- 201000001862 viral hepatitis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102683207A CN102380091A (zh) | 2010-08-31 | 2010-08-31 | 白介素-22在治疗病毒性肝炎中的应用 |
| PCT/CN2011/079124 WO2012028089A1 (zh) | 2010-08-31 | 2011-08-30 | 白介素-22在治疗病毒性肝炎中的应用 |
| EP11821115.0A EP2633865B1 (en) | 2010-08-31 | 2011-08-30 | Use of interleukin-22 in treating viral hepatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2633865T3 true PL2633865T3 (pl) | 2018-05-30 |
Family
ID=45772162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11821115T PL2633865T3 (pl) | 2010-08-31 | 2011-08-30 | Zastosowanie interleukiny-22 w leczeniu wirusowego zapalenia wątroby |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8945528B2 (pl) |
| EP (2) | EP2633865B1 (pl) |
| JP (2) | JP5907970B2 (pl) |
| CN (3) | CN102380091A (pl) |
| AU (1) | AU2011298556B2 (pl) |
| CA (1) | CA2809900C (pl) |
| DK (1) | DK2633865T3 (pl) |
| ES (1) | ES2658309T3 (pl) |
| HU (1) | HUE036564T2 (pl) |
| PL (1) | PL2633865T3 (pl) |
| PT (1) | PT2633865T (pl) |
| TR (1) | TR201802587T4 (pl) |
| WO (1) | WO2012028089A1 (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361968B (zh) | 2007-08-06 | 2011-08-03 | 健能隆医药技术（上海）有限公司 | 白介素-22在治疗脂肪肝中的应用 |
| CN102380091A (zh) | 2010-08-31 | 2012-03-21 | 健能隆医药技术（上海）有限公司 | 白介素-22在治疗病毒性肝炎中的应用 |
| CN103182072B (zh) | 2011-12-27 | 2017-05-03 | 健能隆医药技术（上海）有限公司 | 白介素‑22在治疗和预防神经损伤疾病或神经退行性疾病中的用途 |
| PL2970422T3 (pl) | 2013-03-15 | 2018-09-28 | F.Hoffmann-La Roche Ag | Polipeptydy IL-22 i białka fuzyjne IL-22 Fc i sposoby zastosowania |
| US10646548B2 (en) | 2013-10-08 | 2020-05-12 | Georgia State University Research Foundation, Inc. | Compositions including IL-18 and IL-22 and their use in anti-viral therapies |
| AU2014346554B2 (en) * | 2013-11-07 | 2020-06-04 | Evive Biotechnology (Shanghai) Ltd | Methods of use for IL-22 in the treatment of gastrointestinal graft vs. host disease |
| CN104623637A (zh) * | 2013-11-07 | 2015-05-20 | 健能隆医药技术（上海）有限公司 | Il-22二聚体在制备静脉注射药物中的应用 |
| CN104623639A (zh) * | 2013-11-07 | 2015-05-20 | 健能隆医药技术（上海）有限公司 | 白介素22二聚体在制备治疗胰腺炎药物中的应用 |
| WO2017181143A1 (en) | 2016-04-15 | 2017-10-19 | Generon (Shanghai) Corporation, Ltd. | Use of il-22 in treating necrotizing enterocolitis |
| JP7186401B2 (ja) * | 2017-02-28 | 2022-12-09 | フエー・イー・ベー・フエー・ゼツト・ウエー | タンパク質の経口送達のための手段及び方法 |
| CA3166132A1 (en) * | 2020-02-14 | 2021-08-19 | Zheng Yang | Methods for prevention or treatment of virus-induced organ injury or failure with il-22 dimer |
| EP4106794A4 (en) | 2020-02-19 | 2024-03-20 | Evive Biotechnology (Shanghai) Ltd | METHOD FOR TREATING TRANSPLANT AND HOST DISEASE |
| WO2021207662A1 (en) | 2020-04-10 | 2021-10-14 | Genentech, Inc. | Use of il-22fc for the treatment or prevention of pneumonia, acute respiratory distress syndrome, or cytokine release syndrome |
| US12240879B2 (en) * | 2020-07-30 | 2025-03-04 | Anwita Biosciences, Inc. | Interleukin-22 fusion proteins, and their pharmaceutical compositions |
| AU2023210838A1 (en) * | 2022-01-28 | 2024-08-01 | Fundació Centre De Regulació Genòmica | Therapeutic cytokines and methods |
| US20240277809A1 (en) * | 2023-02-16 | 2024-08-22 | Adonis Sfera | F-652 (recombinant human interleukin-22) for treatment of schizophrenia and psychosis |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US359117A (en) | 1887-03-08 | william whakton | ||
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
| NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| US4943529A (en) | 1982-05-19 | 1990-07-24 | Gist-Brocades Nv | Kluyveromyces as a host strain |
| AU2353384A (en) | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
| US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
| AU3145184A (en) | 1983-08-16 | 1985-02-21 | Zymogenetics Inc. | High expression of foreign genes in schizosaccharomyces pombe |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
| GB8724885D0 (en) | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
| JPH04501201A (ja) | 1987-12-21 | 1992-03-05 | ジ・アップジョン・カンパニー | 発芽植物種子類のアグロバクテリウム媒介形質転換 |
| AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
| EP0394538B1 (en) | 1989-04-28 | 1996-10-16 | Rhein Biotech Gesellschaft Für Neue Biotechnologische Prozesse Und Produkte Mbh | A yeast cell of the genus schwanniomyces |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| FR2649120B1 (fr) | 1989-06-30 | 1994-01-28 | Cayla | Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede |
| JPH08503950A (ja) | 1992-12-02 | 1996-04-30 | アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド | 徐放性成長ホルモン含有マイクロスフェア |
| US5951974A (en) | 1993-11-10 | 1999-09-14 | Enzon, Inc. | Interferon polymer conjugates |
| EP1002529A1 (en) | 1994-09-09 | 2000-05-24 | Takeda Chemical Industries, Ltd. | Sustained-release preparation containing a metal salt of a peptide |
| SK281571B6 (sk) | 1995-06-07 | 2001-05-10 | Alkermes Controlled Therapeutics, Inc. | Prostriedok na trvalé uvoľňovanie ľudského rastového hormónu |
| ZA965368B (en) | 1995-07-14 | 1997-01-14 | Novo Nordisk As | A pharmaceutical formulation |
| US6551799B2 (en) | 1999-12-07 | 2003-04-22 | Genentech, Inc. | Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| JP2002516103A (ja) | 1998-05-29 | 2002-06-04 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | インターロイキン２１およびインターロイキン２２ |
| US6331613B1 (en) | 1998-10-26 | 2001-12-18 | Ludwig Institue For Cancer Research | Isolated nucleic acid molecules which encode T cell inducible factors (TIFS), the proteins encoded, and uses thereof |
| US6274710B1 (en) | 1998-10-26 | 2001-08-14 | Ludwig Institute For Cancer Research | Antibodies which specifically bind T Cell inducible factors (TIFs) |
| US7307161B1 (en) | 1999-04-28 | 2007-12-11 | Genetics Institute, Llc | Human Gil-19/AE289 polynucleotides |
| GB0024442D0 (en) * | 2000-10-05 | 2000-11-22 | Isis Innovation | Genetic factors affecting the outcome of viral infections |
| US6797493B2 (en) * | 2001-10-01 | 2004-09-28 | Lee-Hwei K. Sun | Fc fusion proteins of human granulocyte colony-stimulating factor with increased biological activities |
| US7670595B2 (en) | 2004-06-28 | 2010-03-02 | Merck Patent Gmbh | Fc-interferon-beta fusion proteins |
| CN101027079B (zh) * | 2004-10-12 | 2011-08-17 | 美国蛋白质公司 | 嵌合蛋白 |
| CN100515491C (zh) | 2005-01-04 | 2009-07-22 | 健能隆医药技术（上海）有限公司 | 白介素-22的医药用途 |
| CN101218254A (zh) * | 2005-02-14 | 2008-07-09 | 惠氏公司 | 白介素-17f抗体及其它il-17f信号传递拮抗剂和它们的用途 |
| CN101361968B (zh) | 2007-08-06 | 2011-08-03 | 健能隆医药技术（上海）有限公司 | 白介素-22在治疗脂肪肝中的应用 |
| WO2009041734A1 (ja) * | 2007-09-26 | 2009-04-02 | Kyowa Hakko Kirin Co., Ltd. | ヒトトロンボポエチン受容体に対するアゴニスト抗体 |
| CN101168049A (zh) * | 2007-10-23 | 2008-04-30 | 中国人民解放军军事医学科学院基础医学研究所 | 白介素-22在制备治疗肝病药物中的应用及其制备方法 |
| CN101225110B (zh) | 2007-10-23 | 2010-10-20 | 中国人民解放军军事医学科学院基础医学研究所 | 人白细胞介素-22突变体及其构建方法和应用 |
| US20090202475A1 (en) | 2007-11-07 | 2009-08-13 | Genentech, Inc. | Compositions and methods for treatment of microbial disorders |
| US20130121959A1 (en) | 2010-01-13 | 2013-05-16 | Joseph R. Maxwell | Il-22-fc and hepcidin activity |
| CN102380091A (zh) | 2010-08-31 | 2012-03-21 | 健能隆医药技术（上海）有限公司 | 白介素-22在治疗病毒性肝炎中的应用 |
| JP5044060B2 (ja) | 2010-12-28 | 2012-10-10 | パナソニック株式会社 | 非水電解質二次電池およびその製造方法 |
| CN103182072B (zh) | 2011-12-27 | 2017-05-03 | 健能隆医药技术（上海）有限公司 | 白介素‑22在治疗和预防神经损伤疾病或神经退行性疾病中的用途 |
| JP6188355B2 (ja) | 2013-03-06 | 2017-08-30 | キヤノン株式会社 | 放射線撮影装置、補正方法及びプログラム |
-
2010
- 2010-08-31 CN CN2010102683207A patent/CN102380091A/zh active Pending
-
2011
- 2011-08-30 CN CN201410612763.1A patent/CN104479026B/zh active Active
- 2011-08-30 CN CN201180041737.2A patent/CN103118699B/zh active Active
- 2011-08-30 PT PT118211150T patent/PT2633865T/pt unknown
- 2011-08-30 EP EP11821115.0A patent/EP2633865B1/en active Active
- 2011-08-30 WO PCT/CN2011/079124 patent/WO2012028089A1/zh not_active Ceased
- 2011-08-30 CA CA2809900A patent/CA2809900C/en active Active
- 2011-08-30 JP JP2013526307A patent/JP5907970B2/ja active Active
- 2011-08-30 US US13/819,717 patent/US8945528B2/en active Active
- 2011-08-30 AU AU2011298556A patent/AU2011298556B2/en active Active
- 2011-08-30 HU HUE11821115A patent/HUE036564T2/hu unknown
- 2011-08-30 ES ES11821115.0T patent/ES2658309T3/es active Active
- 2011-08-30 DK DK11821115.0T patent/DK2633865T3/en active
- 2011-08-30 PL PL11821115T patent/PL2633865T3/pl unknown
- 2011-08-30 EP EP17210060.4A patent/EP3332798A1/en not_active Withdrawn
- 2011-08-30 TR TR2018/02587T patent/TR201802587T4/tr unknown
-
2014
- 2014-12-16 US US14/572,429 patent/US9629898B2/en active Active
-
2016
- 2016-01-27 JP JP2016013622A patent/JP6325585B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2633865B1 (en) | 2017-12-27 |
| JP2013536254A (ja) | 2013-09-19 |
| HK1185552A1 (en) | 2014-02-21 |
| CA2809900A1 (en) | 2012-03-08 |
| CN103118699B (zh) | 2014-11-19 |
| PT2633865T (pt) | 2018-03-13 |
| US20130171100A1 (en) | 2013-07-04 |
| EP2633865A4 (en) | 2014-11-12 |
| CN103118699A (zh) | 2013-05-22 |
| US9629898B2 (en) | 2017-04-25 |
| US20150202267A1 (en) | 2015-07-23 |
| EP2633865A1 (en) | 2013-09-04 |
| TR201802587T4 (tr) | 2018-03-21 |
| ES2658309T3 (es) | 2018-03-09 |
| EP3332798A1 (en) | 2018-06-13 |
| AU2011298556B2 (en) | 2015-04-16 |
| CA2809900C (en) | 2018-08-21 |
| JP6325585B2 (ja) | 2018-05-16 |
| WO2012028089A1 (zh) | 2012-03-08 |
| AU2011298556A1 (en) | 2013-04-04 |
| JP5907970B2 (ja) | 2016-04-26 |
| US8945528B2 (en) | 2015-02-03 |
| JP2016128475A (ja) | 2016-07-14 |
| CN104479026A (zh) | 2015-04-01 |
| HUE036564T2 (hu) | 2018-07-30 |
| CN104479026B (zh) | 2019-02-12 |
| CN102380091A (zh) | 2012-03-21 |
| DK2633865T3 (en) | 2018-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE036564T2 (hu) | Interleukin-22 alkalmazása vírusos májgyulladás kezelésében | |
| SI2627334T1 (sl) | Sestavki za uporabo pri zdravljenju virusnih infekcij | |
| PT3042910T (pt) | 2'-espiro-nucleósidos para utilização na terapia da hepatite c | |
| ZA201404061B (en) | Compositions and methods for treating the hepatitis c virus | |
| GB2478595B (en) | Phytocannabinoids in the treatment of glioma | |
| IL253225A0 (en) | Sulfamoyl-arylamides and their use as drugs to treat jaundice b | |
| GB201115711D0 (en) | Phyto-cannabinoids for use in the treatment of cancer | |
| IL221033A0 (en) | Hepatitis c virus inhibitors | |
| IL235990B (en) | Macrocyclic compounds that include a purine residue and their use for the treatment of viral infections | |
| IL232046A (en) | Furein derivatives for the treatment of viral infections | |
| EP2575819A4 (en) | INHIBITORS OF HEPATITIS C VIRUS | |
| GB201120993D0 (en) | Novel compounds and their use in therapy | |
| EP2857466A4 (en) | SURFACE TREATMENT COMPOSITION AND ARTICLE OBTAINED USING THE SAME | |
| IL224298A (en) | Hepatitis virus inhibitors c | |
| PT2838900T (pt) | Compostos e métodos para tratamento antiviral | |
| EP2603080A4 (en) | HEPATITIS C-VIRUS HEMMER | |
| PL2917231T3 (pl) | Lipopeptydy do stosowania w leczeniu chorób wątroby i chorób sercowo-naczyniowych | |
| PL2534150T3 (pl) | Sposoby leczenia infekcji wirusowej | |
| ZA201307058B (en) | Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment | |
| ZA201207226B (en) | Compositions and methods for treating viral diseases | |
| GB201718726D0 (en) | Phytocannabinoids in the treatment of cancer | |
| SG11201402899TA (en) | Methods and compositions for treating viral diseases | |
| GB201116585D0 (en) | Methods and uses in viral infection | |
| GB201014736D0 (en) | Treatment of hepatitis C | |
| IL232889A0 (en) | Compounds and methods for treating hepatitis c virus |